THBD and familial pancreatic carcinoma: (44) described that thrombomodulin degraded HMGB1, which inhibited NET induction, thereby preventing pancreatic cancer metastasis to the liver, and blocked EMT and attenuated the malignant potential of pancreatic cancer cells.